Evaluation of a modified direct agar proportion method for testing susceptibility of Mycobacterium tuberculosis from MGIT samples

Fang Lan Yu, Jau Ching Lee, Mei Shiang Wang, Han Lin Hsu, Tzu Ting Chen, Chia Ling Cheng, Yi Yuan Yang, Giueng Chueng Wang, Ming Chih Yu

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background/Purpose: The emergence of resistance to anti-tuberculosis (TB) drugs has become an obstacle to effective TB control. Thus, there is an urgent need to identify patients and initiate adequate treatment for drug-resistant cases in a timely manner. The BACTEC MGIT 960 system is well known for its rapid culturing time, and is in widespread use in Taiwan. In this study, we evaluated the possibility of replacing the traditional indirect agar proportion method with a modified direct agar proportion method (MDAPM), as a technique for rapid testing the drug susceptibility of Mycobacterium tuberculosis without additional cost. Methods: In this study, 432 positive MGIT 960 samples that were identified as M. tuberculosis complex using the MeDiPro M. tuberculosis Antigen Rapid Test or the Cobas Amplicor MTB test were evaluated. Each sample was tested separately by the MDAPM and indirect agar proportion method, between July 2008 and December 2008, to compare the consistency and total turnaround time. Results: Four first-line anti-TB drugs-rifampin, isoniazid, ethambutol, and streptomycin-were tested. For the MDAPM and indirect agar proportion method, the respective consistencies for each drug were 99.31%, 98.38%, 98.38%, and 97.22%. Our results also indicated that the MDAPM leads to an average saving in working time of 2 weeks, compared with the traditional indirect agar proportion method. Conclusion: In addition to having the potential to shorten turnaround time without compromising diagnostic quality, the MDAPM also provides a more efficient and cost-effective procedure. This modified procedure presents potential benefits for TB diagnosis in laboratories already equipped with the MGIT 960 system.

Original languageEnglish
Pages (from-to)60-65
Number of pages6
JournalJournal of Microbiology, Immunology and Infection
Volume49
Issue number1
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Mycobacterium tuberculosis
Agar
Tuberculosis
Pharmaceutical Preparations
Costs and Cost Analysis
Ethambutol
Clinical Laboratory Techniques
Isoniazid
Streptomycin
Rifampin
Taiwan

Keywords

  • BACTEC MGIT 960 system
  • Indirect agar proportion method
  • Modified direct agar proportion method
  • Mycobacterium tuberculosis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Allergy
  • Immunology and Microbiology(all)
  • Infectious Diseases

Cite this

Evaluation of a modified direct agar proportion method for testing susceptibility of Mycobacterium tuberculosis from MGIT samples. / Yu, Fang Lan; Lee, Jau Ching; Wang, Mei Shiang; Hsu, Han Lin; Chen, Tzu Ting; Cheng, Chia Ling; Yang, Yi Yuan; Wang, Giueng Chueng; Yu, Ming Chih.

In: Journal of Microbiology, Immunology and Infection, Vol. 49, No. 1, 01.02.2016, p. 60-65.

Research output: Contribution to journalArticle

Yu, Fang Lan ; Lee, Jau Ching ; Wang, Mei Shiang ; Hsu, Han Lin ; Chen, Tzu Ting ; Cheng, Chia Ling ; Yang, Yi Yuan ; Wang, Giueng Chueng ; Yu, Ming Chih. / Evaluation of a modified direct agar proportion method for testing susceptibility of Mycobacterium tuberculosis from MGIT samples. In: Journal of Microbiology, Immunology and Infection. 2016 ; Vol. 49, No. 1. pp. 60-65.
@article{5aa2ed86faab43cd961ceb96c651f5d1,
title = "Evaluation of a modified direct agar proportion method for testing susceptibility of Mycobacterium tuberculosis from MGIT samples",
abstract = "Background/Purpose: The emergence of resistance to anti-tuberculosis (TB) drugs has become an obstacle to effective TB control. Thus, there is an urgent need to identify patients and initiate adequate treatment for drug-resistant cases in a timely manner. The BACTEC MGIT 960 system is well known for its rapid culturing time, and is in widespread use in Taiwan. In this study, we evaluated the possibility of replacing the traditional indirect agar proportion method with a modified direct agar proportion method (MDAPM), as a technique for rapid testing the drug susceptibility of Mycobacterium tuberculosis without additional cost. Methods: In this study, 432 positive MGIT 960 samples that were identified as M. tuberculosis complex using the MeDiPro M. tuberculosis Antigen Rapid Test or the Cobas Amplicor MTB test were evaluated. Each sample was tested separately by the MDAPM and indirect agar proportion method, between July 2008 and December 2008, to compare the consistency and total turnaround time. Results: Four first-line anti-TB drugs-rifampin, isoniazid, ethambutol, and streptomycin-were tested. For the MDAPM and indirect agar proportion method, the respective consistencies for each drug were 99.31{\%}, 98.38{\%}, 98.38{\%}, and 97.22{\%}. Our results also indicated that the MDAPM leads to an average saving in working time of 2 weeks, compared with the traditional indirect agar proportion method. Conclusion: In addition to having the potential to shorten turnaround time without compromising diagnostic quality, the MDAPM also provides a more efficient and cost-effective procedure. This modified procedure presents potential benefits for TB diagnosis in laboratories already equipped with the MGIT 960 system.",
keywords = "BACTEC MGIT 960 system, Indirect agar proportion method, Modified direct agar proportion method, Mycobacterium tuberculosis",
author = "Yu, {Fang Lan} and Lee, {Jau Ching} and Wang, {Mei Shiang} and Hsu, {Han Lin} and Chen, {Tzu Ting} and Cheng, {Chia Ling} and Yang, {Yi Yuan} and Wang, {Giueng Chueng} and Yu, {Ming Chih}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.jmii.2014.01.003",
language = "English",
volume = "49",
pages = "60--65",
journal = "Journal of Microbiology, Immunology and Infection",
issn = "0253-2662",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

TY - JOUR

T1 - Evaluation of a modified direct agar proportion method for testing susceptibility of Mycobacterium tuberculosis from MGIT samples

AU - Yu, Fang Lan

AU - Lee, Jau Ching

AU - Wang, Mei Shiang

AU - Hsu, Han Lin

AU - Chen, Tzu Ting

AU - Cheng, Chia Ling

AU - Yang, Yi Yuan

AU - Wang, Giueng Chueng

AU - Yu, Ming Chih

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Background/Purpose: The emergence of resistance to anti-tuberculosis (TB) drugs has become an obstacle to effective TB control. Thus, there is an urgent need to identify patients and initiate adequate treatment for drug-resistant cases in a timely manner. The BACTEC MGIT 960 system is well known for its rapid culturing time, and is in widespread use in Taiwan. In this study, we evaluated the possibility of replacing the traditional indirect agar proportion method with a modified direct agar proportion method (MDAPM), as a technique for rapid testing the drug susceptibility of Mycobacterium tuberculosis without additional cost. Methods: In this study, 432 positive MGIT 960 samples that were identified as M. tuberculosis complex using the MeDiPro M. tuberculosis Antigen Rapid Test or the Cobas Amplicor MTB test were evaluated. Each sample was tested separately by the MDAPM and indirect agar proportion method, between July 2008 and December 2008, to compare the consistency and total turnaround time. Results: Four first-line anti-TB drugs-rifampin, isoniazid, ethambutol, and streptomycin-were tested. For the MDAPM and indirect agar proportion method, the respective consistencies for each drug were 99.31%, 98.38%, 98.38%, and 97.22%. Our results also indicated that the MDAPM leads to an average saving in working time of 2 weeks, compared with the traditional indirect agar proportion method. Conclusion: In addition to having the potential to shorten turnaround time without compromising diagnostic quality, the MDAPM also provides a more efficient and cost-effective procedure. This modified procedure presents potential benefits for TB diagnosis in laboratories already equipped with the MGIT 960 system.

AB - Background/Purpose: The emergence of resistance to anti-tuberculosis (TB) drugs has become an obstacle to effective TB control. Thus, there is an urgent need to identify patients and initiate adequate treatment for drug-resistant cases in a timely manner. The BACTEC MGIT 960 system is well known for its rapid culturing time, and is in widespread use in Taiwan. In this study, we evaluated the possibility of replacing the traditional indirect agar proportion method with a modified direct agar proportion method (MDAPM), as a technique for rapid testing the drug susceptibility of Mycobacterium tuberculosis without additional cost. Methods: In this study, 432 positive MGIT 960 samples that were identified as M. tuberculosis complex using the MeDiPro M. tuberculosis Antigen Rapid Test or the Cobas Amplicor MTB test were evaluated. Each sample was tested separately by the MDAPM and indirect agar proportion method, between July 2008 and December 2008, to compare the consistency and total turnaround time. Results: Four first-line anti-TB drugs-rifampin, isoniazid, ethambutol, and streptomycin-were tested. For the MDAPM and indirect agar proportion method, the respective consistencies for each drug were 99.31%, 98.38%, 98.38%, and 97.22%. Our results also indicated that the MDAPM leads to an average saving in working time of 2 weeks, compared with the traditional indirect agar proportion method. Conclusion: In addition to having the potential to shorten turnaround time without compromising diagnostic quality, the MDAPM also provides a more efficient and cost-effective procedure. This modified procedure presents potential benefits for TB diagnosis in laboratories already equipped with the MGIT 960 system.

KW - BACTEC MGIT 960 system

KW - Indirect agar proportion method

KW - Modified direct agar proportion method

KW - Mycobacterium tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84958049739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958049739&partnerID=8YFLogxK

U2 - 10.1016/j.jmii.2014.01.003

DO - 10.1016/j.jmii.2014.01.003

M3 - Article

VL - 49

SP - 60

EP - 65

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

SN - 0253-2662

IS - 1

ER -